– FDA confirmed that the ongoing Phase 1/2 single arm study will serve as pivotal and no additional randomized, placebo-controlled trial will be required to support submission of a BLA – – FDA agreed on the required efficacy and safety endpoints that will support filing an accelerated…

THE WOODLANDS, Texas, Aug. 9, 2023 /PRNewswire/ — Target Hospitality Corp. (“Target Hospitality”, “Target” or the “Company”) (NASDAQ: TH), one of North America’s largest providers of vertically-integrated modular accommodations and value-added hospitality services, today reported results…

LONDRES, 9 août 2023 /PRNewswire/ — L’Institute of Risk Management (IRM), organisme professionnel mondial de premier plan dans le domaine de la gestion des risques, a le plaisir d’annoncer avoir obtenu l’accréditation de l’OFQUAL pour son certificat international en gestion des risques…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.